Clinical trial
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic…
NCT00424372 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00424372 |
|---|---|
| Title | A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia |
| Official title | A LONG-TERM STUDY TO EVALUATE SAFETY AND EFFICACY STUDY OF PREGABALIN IN THE TREATMENT OF POSTHERPETIC NEURALGIA. |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuralgia, Postherpetic |
| Intervention type | Drug |
| Interventions | pregabalin |
| Enrollment | 126 |
| Start date | Jan 12, 2007 |
| Primary completion | Aug 19, 2008 |
| Completion | Aug 19, 2008 |
| First posted | Jan 19, 2007 |
| Last update posted | Aug 27, 2021 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: